Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPECT: Enoxaparin and Chemotherapy in Pancreatic Cancer
NCT00785421Phase 3Completed
- Start
- Apr 2004
- Primary completion
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of enoxaparin in venous thromboembolism (VTE) (2 arms). Primary endpoint: Deep Venous Thrombosis / Venous Thromboembolism event rate. Started Apr 2004; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00785421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785421.